NOV 28, 2015 10:56 AM PST

Functional Human Liver Cells Successfully Grown in Lab

WRITTEN BY: Julianne Chiaet
A group of German and Israeli scientists have successfully grown human liver cells in the laboratory that did not lose their metabolic function.  

The cells, called hepatocytes, make up about 80 percent of the liver’s mass. The human liver is the only organ that has the ability to rapidly regenerate lost tissue. As little as 25 percent of a liver can regenerate into a whole liver.

Unfortunately, hepatocytes lose their regenerative ability when removed from the body. Scientists who previously tried to tackle the problem ended up with cancer cells with little metabolic function. This inability has been a major obstacle for scientific, clinical and pharmaceutical development.
 
Fluorescently labeled polarized Upcyte® hepatocytes.

The scientists based their research on the German Cancer Research Center’s early work on HPV. They demonstrated that weak expression of Human Papilloma Virus (HPV) E6 and E7 proteins released hepatocytes from cell-cycle arrest, a stopping point in the cell cycle. The expression allowed the released hepatocytes to rapidly increase in response to Oncostatin M (OSM), a protein important in liver regeneration. Thus, the stimulation of OSM caused the cells to rapidly multiply.

They were careful to select colonies of human hepatocytes that only rapidly multiplied in response to OSM. The cells doubling time was 33 to 49 hours. Removal of OSM caused the cell to stop growing and, within 4 days, become highly functional liver cells. The method, called the upcyte© process, allows the cells to double 35 times since their primary isolation in the lab; resulting in approximately 1015 quadrillion cells from each liver isolation.


The strength of method lies in its ability to generate liver cells from multiple donors of ethnically diverse backgrounds, said biochemist Joris Braspenning, who led the German group. "[It enables] the study of patient-to-patient variability and idiosyncratic toxicity."

“Our technology will enable thousands of laboratories to study fatty liver disease, viral hepatitis, drug toxicity and liver cancer at a fraction of the current cost,” lead author and biomedical engineer Yaakov Nahmias said. The pharmaceutical industry routinely uses human hepatocytes when studying the major problem of hepatotoxicity, liver damage caused by a chemical or medicine. It is the most common reason for a drug to be withdrawn from the market. The development could additionally advance creating bio-artificial liver support for patients awaiting transplantations. 

The study was published online on October 26, 2015, by the journal Nature Biotechnology.

Source: The Hebrew University of Jerusalem via Science Daily
 
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to Jchiaet.com
You May Also Like
MAR 10, 2021
Microbiology
Gut Microbes Could be a Way to Treat Some Neurological Disorders
MAR 10, 2021
Gut Microbes Could be a Way to Treat Some Neurological Disorders
Researchers and clinicians have often studied genes that affect the function and development of the brain to explain neu ...
MAR 11, 2021
Cell & Molecular Biology
Deadly Cancer Cells Can Move in the Wrong Direction
MAR 11, 2021
Deadly Cancer Cells Can Move in the Wrong Direction
Cancer is most deadly when it metastasizes; when cells break away from a primary site of cancer and move through the bod ...
MAR 15, 2021
Cell & Molecular Biology
Newly-ID'ed Organelle May Play a Role in Cancer Metastasis
MAR 15, 2021
Newly-ID'ed Organelle May Play a Role in Cancer Metastasis
Cells are packed full of organelles and molecules like proteins floating in a liquid known as cytoplasm. In recent years ...
MAR 21, 2021
Cell & Molecular Biology
A Model of Early Human Development is Created
MAR 21, 2021
A Model of Early Human Development is Created
Scientists now have a new way to investigate the processes underlying human development, diseases that may arise during ...
MAR 28, 2021
Genetics & Genomics
Fish Oil Benefits May Depend on a Person's Genetics
MAR 28, 2021
Fish Oil Benefits May Depend on a Person's Genetics
The benefits of fish oil have been debated for years. New research can explain why it's been difficult to reach a solid ...
MAR 30, 2021
Neuroscience
Prolonged Amygdala Activity Predicts Personal Wellbeing
MAR 30, 2021
Prolonged Amygdala Activity Predicts Personal Wellbeing
Researchers have found that activity in the amygdala (the emotional center of the brain) following exposure to negative ...
Loading Comments...